ArticleScientific reports2024

A randomized clinical trial evaluating Hydralazine's efficacy in early-stage Alzheimer's disease: The EHSAN Study.

Masoud Mirzaei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.